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Abstract
The opioid crisis continues to be a public health concern. Traditionally, an opioid-centric
approach treats postoperative pain. The following PICOT question guided this project: Will
initiating a multimodal analgesic virtual reality quality improvement program (I) compared to
current practice (C) decrease opioid requirements (O) in robotic hysterectomy patients (P) during
the postoperative period (T)? Several articles promote non-opioid analgesia and nonpharmacological interventions, such as multimodal analgesia and virtual reality (VR) for pain
management. This project reviewed pre- and post-implementation data after implementing new
evidence-based multimodal analgesia and VR protocols. The project captured a total of 64
patients in the pre-implementation group. A total of 22 patients received both multimodal
analgesia and VR in the post-implementation group. There was no statistically significant
difference in total opioid consumption converted as morphine milligram equivalents (MME)
between the pre-implementation and post-implementation groups. However, there was a
statistically significant difference in multimodal analgesia administered in Pre-op between the
pre-implementation and post-implementation groups. In conclusion, the execution of the
multimodal analgesic VR program allowed for nursing adoption of novel evidence-based
practices (EBP) and promoted the use of non-opioid and non-pharmacological interventions.
Although the combination of multimodal analgesia and VR did not reduce opioid consumption,
the practice of incorporating multimodal analgesia as a standard workflow improved.
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A Multimodal Analgesic and Virtual Reality Program to Reduce Opioid Exposure
Federal involvement in combatting the national opioid crisis began in the 1970s when
Title II of the Comprehensive Drug Abuse Prevention and Control Act was passed (Gross &
Gordon, 2019). This act, also known as the Controlled Substances Act (CSA), required federal
regulation of controlled substances and included formal recommendations for scheduling
substances related to their potential for abuse (United States Drug Enforcement Act, n.d.). Both
cultural changes and prescribing patterns detrimentally evolved during the 1990s (Baker, 2017)
as healthcare accreditors began tethering patient satisfaction to the frequency of clinician pain
management interventions (Ashburn & Fleisher, 2016). Between 1991 to 2013, the number of
prescribed medications increased from 76 million to 97 million, an upward spiraling trend that
may have been caused by the Food and Drug Administration’s (FDA) release of OxyContin
(Baker, 2017). OxyContin's manufacturers aggressively marketed towards high-prescribing
physicians and released information that the medication was best suited for the treatment for
non-cancer-related pain due to its low-risk for iatrogenic addiction (Zee, 2009). It was not until
2010 that the Affordable Care Act (ACA) required the Department of Health and Human
Services (HHS) to declare pain as a public health concern (“Relieving Pain in America,” 2016).
In December 2015, clinical practice guidelines emerged on the management of
postoperative pain from the American Pain Society, the American Society of Regional
Anesthesia, the American Society of Regional Anesthesia and Pain Medicine, and the American
Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and
Administrative Council (Chou et al., 2015). Among some of the strong recommendations
included providing patient and family-centered preoperative education and planning,
administering multimodal therapies (including non-pharmacological techniques), and utilizing
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oral opioids versus intravenous (IV) opioids because of their superior effects on postoperative
pain.
With the call to change health care culture from opioid-centric to opioid-sparing, a
concerted effort from perioperative clinicians is required to manage postoperative pain optimally.
In one study, 10% of opioid naïve patients undergoing short-stay or same-day surgery and given
low-dose opioid prescription for pain became long-term opioid users after one year (Alam,
Gomes, Zheng, Mamdani, Juurlink, & Bell, 2012). Therefore, limiting the exposure during the
immediate postoperative period may impact patient opioid usage in the long-run.
Making a difference globally, nationally, and at the state level to formally fight against
the opioid epidemic requires strategic planning and ongoing commitment. One hospital in
Southern California equipped its perioperative staff with virtual reality (VR), an innovative,
disruptive technology. According to one meta-analysis, the authors concluded that VR is a
useful pain management tool that reduces acute pain during medical procedures (Mallari, Spaeth,
Goh, & Boyd, 2019). The purpose of this Doctor of Nursing Practice (DNP) project is to
evaluate the implementation of a structured multimodal analgesic and virtual reality program to
decrease opioid exposure and usage while effectively managing postoperative pain.
Significance of the Practice Problem
Millions of surgeries occur every year to heal or save lives (Meara et al., 2016).
Unfortunately, the prevalence of poorly controlled postoperative pain due to adverse events
continues to be the unresolved reality for many patients. The estimated cost to healthcare
organizations is US $1,869±4,553 per patient (Gan, 2017). According to the Institute of
Medicine (IOM), patients report pain after surgery 80% of the time, with varying levels ranging
from moderate to severe and extreme (IOM, 2011). To address postoperative pain, surgeons
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prescribe analgesic medications after surgery (Gan, Epstein, Leone-Perkins, Salimi, Iqbal, &
Whang, 2018). Commonly, these medications include IV opioids such as morphine,
hydromorphone, and fentanyl. One study by Gan et al. (2018) found that 45% of physicians
surveyed were not concerned with the patient’s risk of addiction in combination with acute usage
of postoperative IV opioids. In another study, 6% of patients continued to take opioids after 90
days following both major and minor surgery (Brummet et al., 2017). This research suggested
that more than 2 million patients transition from acute to chronic opioid consumption every year.
About 80% of heroin abuser’s habits stem from opioids prescribed by doctors (Adams,
Bledsoe, & Armstrong, 2016). Around 450,000 drug-related deaths were reported globally in
2015, with 160,000 related to drug use overdose and 118,000 pertaining to opioid use disorders
(World Health Organization [WHO], 2018). In the United States, opioids caused more than half
of the 70,200 drug overdose deaths reported in 2017, and about 130 Americans die from an
opioid overdose daily (Centers for Disease Control [CDC], 2018). In the same year, over 11.4
million people abused their opioid prescriptions (U.S. Department of Health and Human Services
[HHS], 2019). Interestingly in California, most opioid-related deaths are from prescription
opioids, compared to synthetic opioids and heroin (National Institute on Drug Abuse [NIDA],
2019).
Postoperative pain can result from nociceptive pain, or a neuronal response to noxious
stimuli (Czarnecki & Turner, 2018). Two types of nociceptive pain exist; somatic (localized,
present in the skin, tissue, muscles, or bones) and visceral (diffuse, originating from deep inside
the body). Both peripheral and central sensitizing factors are the consequence of postoperative
pain, which requires adequate control through various opioid and non-opioid techniques (Luo &
Min, 2017). Traditionally, an opioid-centric approach to postoperative pain management has
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been used by clinicians (McEvoy et al., 2017). However, several articles promote a shift in
tactics through minimizing opioid analgesia and incorporating non-opioid treatment modalities
(Chou et al., 2015; Jones, Viswanath, Peck, Kaye, Gill, & Simopoulous, 2018; McEvoy et al.,
2017).
Patients undergoing total laparoscopic hysterectomies typically experience the most
intense incisional and visceral pain 30 minutes after surgery, and the pain gradually decreases
over time (Choi, Kang, Song, Seok, Kim, & Kim, 2016). One study found that gynecologists
prescribe two times the amount of opioids than the average consumption after a hysterectomy
procedure and cite multifactorial reasons for this practice, such as patient satisfaction and
reduced postoperative calls for refills (As-Sanie et al., 2017). Within the last three years, the
robotic approach to gynecological surgery has become the surgical standard (Wright, et al.,
2013), since the technology allows for easy adaptation from laparoscopic techniques (Lane,
2018). Surgeons appreciate the robotic approach for accuracy and precision because it allows for
minimal invasiveness, an optimal field of view, and improved dexterity (Shah, Vyas, & Vyas,
2014). However, despite significant pain reduction with the robotic approach compared to the
vaginal approach, morphine consumption remained the same in the recovery room in one study
(Carbonnel et al., 2013). This suggests opioid-centric clinician culture persists despite improved
outcomes.
PICOT Question
The following PICOT question guided this project: Will initiating a multimodal
analgesic virtual reality quality improvement program (I) compared to current practice (C)
decrease opioid requirements (O) in robotic hysterectomy patients (P) during the postoperative
period (T)?
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During a post anesthesia care unit (PACU) chart audit, robotic hysterectomy patients
consumed the second-highest amounts of opioids in the recovery room. This population was
chosen to best control the environment during the project pilot due to their high volumes of
surgeries each week and outpatient status. Implementing a standardized multimodal
postoperative analgesic protocol has been shown to improve pain management and reduce opioid
consumption (Walker et al., 2019). Therefore, this project compared the new implementation of
a multimodal analgesic virtual reality program against current unstandardized pain management
practices and measured the total opioid administration converted as morphine milligram
equivalents (MME). The definition of the postoperative period includes the time the patient is
admitted to the PACU (including both Phase 1 and Phase 2) until the patient is discharged home.
Framework of the Problem
Framework
In the clinical setting, the PDSA cycle tests change and allows stakeholders to adopt new
knowledge quickly (Picarillo, 2018). The Associates in Process Improvement cofounders further
expanded the model to answer three questions and named it the Model for Improvement (Crowl,
Sharma, Sorge, & Sorensen, 2015; Joshi, Ransom, Nash, & Ransom, 2014). The questions
included: (1) What are we trying to accomplish?, (2) How will we know that a change is an
improvement?, and (3) What change can we make that will result in improvement? The Model
for Improvement was used as the framework to implement this DNP Project. It provided the
structure for the project to positively impact clinical outcomes, organizational costs, and
productivity (Crowl et al., 2015).
The Model for Improvement helped define this project’s aims and outcomes (Crowl et
al., 2015) and established a SMART (specific, measurable, attainable, realistic, and timely, [Dye,
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2017]) goal. By providing virtual reality as a non-pharmacological intervention, can nurses
decrease opioid exposure by 10% (a hospital executive goal) within the patient’s recovery
period? Multimodal analgesia, also known as providing the patient with two or more drugs or
interventions that provide analgesic relief (American Society of Anesthesiologists Task Force,
2012), is today’s standard (Mariano & Schatman, 2019). This concept is an integral component
of enhanced recovery after surgery (ERAS) protocols (Montgomery & McNamara, 2016;
Pogatzki-Zahn, Segelcke, & Schug, 2017; Tan, Law, & Gan, 2014), something already
established at the hospital of study. Therefore, to answer the second question, this project would
need to show decreased opioid administration and an increase in multimodal techniques to
benefit the patient’s surgical experience. The third question, “What change can we make that
will result in improvement?” will be answered by focusing on a specific patient population
(Crowl et al., 2015) that will benefit the most from this program.
Change Theory
Everett Roger’s Diffusion of Change Theory is the foundation of this project as it
describes the process of adopting innovations in healthcare (Dearing & Cox, 2018). Dearing &
Cox (2018) defined diffusion as a social process among organizational stakeholders resulting
from an evidence-based, innovative change. The process is dependent on when the change is
adopted and accelerated by the perceived relative advantage (Lundblad, 2003). If the
stakeholders’ values align with the project’s mission, there is greater compatibility and
trialability. Every individual’s needs vary and affect their appraisal of the innovation’s
advantages and disadvantages (Dearing & Cox, 2018).
Evidence Search Strategy
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To most effectively explore multimodal pain management and virtual reality, an
exhaustive systematic review of the literature occurred. The search included the following
Medical Subject Headings (MESH) terms: “pain management,” “pain management/methods,”
“pain, postoperative,” “analgesics, non-narcotic,” and “virtual reality.” Databases used to
conduct the search included CINAHL, EBSCO, ProQuest, and PubMed and included only
primary sources. The following inclusion criteria were applied: (1) participants studied ≥ 18
years of age, (2) multimodal and/or non-pharmacologic approach to pain management, (3)
articles written in English, (4) articles published within the last five years (2015-2020).
Exclusion criteria included (1) participants studied < 18 years of age, (2) opioid approach to pain
management, (3) non-English articles, (4) secondary sources, and (5) articles published more
than five years ago.
The foundations of multimodal and non-pharmacologic approaches to pain management
helped find superior methods compared to high-dose opioid administration. Articles were
retained if they were relevant and less than five years old. Duplicated articles were eliminated.
After applying the inclusion and exclusion criteria, 13 articles were chosen; 6 articles were based
on multimodal analgesia, and 7 pertained to virtual reality as a non-pharmacological
intervention.
Evidence Search Results and Evaluation
A review of the literature allowed for an extensive exploration of evidence-based
practices (EBPs) to help create a multimodal analgesic VR program. An initial search using the
Boolean operator “AND,” as well as the MESH terms “pain management,” “pain
management/methods,” “pain postoperative,” and “analgesics, non-narcotic” produced 57
articles. Searching the MESH terms “virtual reality” and “pain management” with the Boolean
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operator “AND” resulted in 29 articles. The initial search resulted in a total of 86 articles. After
completing a review of the abstracts and inclusion and exclusion criteria were applied, a
thorough examination of 19 articles commenced. A total of 6 articles were removed due to
secondary research and protocol-only designs, and a sum of 13 articles emerged for synthesis.
See the PRISMA Flow Diagram in Figure 1.
One reviewer analyzed the articles in a standardized manner and utilized the Johns
Hopkins Nursing Evidence-Based Practice Appraisal Tool to consider the literature's level of
evidence and quality. Types of studies retained included retrospective cohort studies, quasiexperimental research, randomized control trials, randomized comparative effectiveness trials,
non-experimental correlational research, and meta-analysis/systematic reviews. The level of
evidence ranged from I-V (2 level I, 3 level II, 4 level III, and 3 level V). The majority of
articles received a “Good” to “High” quality grade. Only one study was deemed “Low” quality
due to insufficient data analysis information. One randomized controlled trial and three
systematic reviews added strength to the evidence found.
Themes from the Evidence
The literature review identified the general characteristics of a successful pain
management program. A synthesis matrix developed contrasting concepts and underlying ideas
(see both Appendix and B). Similar themes included multimodal analgesia, clinician culture
related to pain management, the benefits of reducing opioids in the perioperative period, and
virtual reality as a non-pharmacological intervention.
Multimodal Analgesia
Several studies support the use of non-opioid analgesics (acetaminophen, NSAIDs, COX2 inhibitors, and gabapentin/pregabalin) both preoperatively and postoperatively to improve pain
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management (Cozowics et al., 2019, Smith, Young, Blosser, & Poole, 2019; Desai et al., 2018;
Militsakh et al., 2018; Brandal et al., 2017; Brubaker, Kendall, & Reina, 2016). One highquality retrospective cohort study saw a substantial reduction in opioids as COX-2 inhibitors and
NSAIDs were administered (Cozowics et al., 2019). Contrastingly, another good quality
retrospective cohort study found that as acetaminophen use per day increased in combination
with NSAID administration, the primary outcome of median morphine milligram equivalents
administered reduced (Smith et al., 2019).
Adverse effects were significantly reduced as a result of less opioid usage, which
included a decrease in postoperative ventilation, critical care admission, obstructive sleep apnea
(OSA), gastrointestinal complications (i.e., ileus; Cozowics, 2019), and decreased lengths of stay
(Cozowics, 2019; Brandal et al., 2017). Adversely, Cozowics (2019) also pointed out that
genitourinary complications did not increase as a result of the non-opioids used, suggesting that
renal toxicity is not a risk factor associated with multimodal analgesia.
Clinician Culture
Healthcare providers can shift cultural perceptions to implement effective postoperative
analgesia (Militsakh, 2018). There is an associated learning curve with the adoption of new
methods of practice. Buy-in and adherence increase over time as clinicians denounce traditional
perspectives of pain management. Although reticence may act as a barrier, witnessing the
positive effects of alternative analgesia administration greatly impacts clinician behavior.
While most studies allude to clinician awareness, one study highlighted physician
behavior as a barrier to proper opioid management (Brandal et al., 2017). Standard discharge
order sets do not allow for customizable opioid prescribing; rather, they make it easier for
physicians to order opioids on every patient. The study suggested educating physicians to
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modify prescribing behaviors by evaluating objective data more thoroughly and following
clinical practice guidelines to minimize opioid prescribing.
Reducing Opioids in the Perioperative Period
A similar theme throughout the literature revealed how the perioperative period creates
an essential opportunity to stave chronic opioid usage since opioids are typically introduced to
opioid-naïve patients postoperatively (Militsakh, 2018; Brandal et al., 2017). It is evident that
reducing the availability of opioids can impact the opioid epidemic positively (Militsakh, 2018).
Integrating non-opioid approaches in the hospital can reduce the administration of opioids (Smith
et al., 2019), thereby reducing exposure and exploitation of high-risk drugs.
Virtual Reality
Similar to the non-opioid approaches, VR is a non-pharmacological intervention that can
benefit patients’ pain with minimal side effects (Spiegel et al., 2019; Chan, Foster, Sambell, &
Leong, 2018; Vazquez, Lara, Miller, Wiederhold, & Wiederhold, 2019; Glennon et al., 2018;
Mohammad & Ahmad, 2018, Scapin, Echevarria-Guanilo, Junior, Goncalves, Rocha, &
Coimbra, 2018). The use of technology to distract the patient from their pain complements
traditional pain management methods. VR is a superior tactic compared to other mediums, such
as television (Speigel et al., 2019) or music (Glennon et al., 2018). The technology can treat
acute pain intraoperatively or during medical procedures, but long-term carryover effects have
not been proven (Mallari et al., 2019). However, one study proved VR’s immediate pain
reduction effects postoperatively (Glennon et al., 2018). Nurses commonly utilize the
technology within the literature (Spiegel et al., 2019; Mohammad & Ahmad, 2018; Scapin et al.,
2018), since it enhances their workflow, such as during painful dressing changes (Scapin et al.,
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2018). While VR can be used to improve pain, it can also significantly reduce anxiety (Glennon
et al., 2018; Mohammad & Ahmad, 2018).
Interestingly, one high-quality randomized comparative effectiveness trial found similar
physician opioid prescribing practices in the study by Brandal et al. (2017), despite changes to
pain management interventions (Spiegel et al., 2019). The study found that usual practice and
equivalent MME administration had higher pain scores than the VR group, providing evidence
that changes to prescribing practices are needed.
There was a high risk of bias in the systematic review by Chan et al. (2018). Many
studies lacked prospective enrollment and rigorous adherence to CONSORT guidelines. It is
also challenging to blind a participant to VR as an intervention. Therefore, future high-quality
studies should be conducted to confirm the effects of VR.
The findings from this literature are multifaceted and recommend implementing multiple
non-opioid medications or non-pharmacologic interventions, such as VR, to improve pain
management from a nursing perspective. A primary limitation of this review included a lack of
randomized control trials to recommend multimodal analgesia and virtual reality strongly. Most
of the studies supported further research in various clinical settings.
Practice Recommendations
Based on a thorough review of the literature, the documentation supports a multifactorial
approach to pain management in the form of both non-opioid and non-pharmacological
interventions. It is strongly recommended with moderate-quality evidence to incorporate
acetaminophen, NSAIDs, COX-2 inhibitors, and gabapentin/pregabalin throughout the entire
perioperative period (Cozowics et al., 2019, Smith, Young, Blosser, & Poole, 2019; Desai et al.,
2018; Militsakh et al., 2018; Brandal et al., 2017; Brubaker, Kendall, & Reina, 2016). The
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addition of VR to an analgesic regimen was also strongly recommended with moderate quality
evidence to decrease pain (Spiegel et al., 2019; Chan, Foster, Sambell, & Leong, 2018; Vazquez,
Lara, Miller, Wiederhold, & Wiederhold, 2019; Glennon et al., 2018; Mohammad & Ahmad,
2018, Scapin, Echevarria-Guanilo, Junior, Goncalves, Rocha, & Coimbra, 2018). Both practices
improve pain management and contribute to higher patient satisfaction while reducing the risk of
opioid-related adverse effects. Therefore, these practice recommendations will be incorporated
into this program.
Considering the Guidelines on the Management of Postoperative Pain, similar
recommendations exist regarding multimodal therapies and cognitive-behavioral modalities. The
panel recommended combining treatments, utilizing both analgesic medications and nonpharmacologic interventions as synergistic mechanisms of action to provide adequate pain relief
(Chou et al., 2016). Although the recommendation in the guidelines for cognitive-behavioral
modalities is weak with moderate-quality evidence, they are noninvasive, minimal risk
interventions with positive effects on postoperative pain and anxiety.
There is strong evidence that supports patient and family-centered preoperative education
and planning (Chou et al., 2016). Customized programs for a heterogeneous patient population
can improve postoperative opioid consumption by managing patient expectations and allowing
autonomy in the decision-making process. Also, the use of short-acting oral opioids versus IV
opioids is strongly recommended with moderate-quality evidence. Nevertheless, nurses should
include discharge education on tapering, discontinuation, and proper disposal of opioids. A
visual Venn diagram highlights the structure of the Multimodal Analgesic Virtual Reality
program (see Figure 2).
Project Setting
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This DNP EBP change project took place in a large, nonprofit acute-care community
hospital located in Southern California. As one of the largest hospitals in Orange County, its
mission is to provide the highest quality care to its surrounding communities as a trusted and
nationally recognized health care leader with 588 licensed beds. The population surrounding the
hospital and its institutes includes close to 2 million residents, which comprises 21.9%
children/youth, 63.9% adults, and 14.1% seniors. The population’s ethnic backgrounds include
White (46.4%), Hispanic or Latino (31.1%), Asian (18.1%), and other races (5.5%).
The perioperative environment consists of three nursing units: Preoperative/Same-DayServices Unit (SDS), Operating Room (OR), and Post Anesthesia Care Unit (PACU).
Implementation of the project occurred on the second-floor pavilion with six dedicated OR
suites. Both the Pavilion SDS and PACU have twelve patient bays with up to six nurses staffing
each unit, depending on the caseload, acuity levels, and census.
Needs Assessment
In January 2020, the hospital gained recognition as a Center of Excellence in Robotic
Surgery. However, a needs assessment and practice gap analysis revealed that the robotic
hysterectomy patients were the second-highest consumers of opioids in the PACU compared to
other procedures. Based on the population’s opioid consumption and outpatient status, the
robotic hysterectomy patient population became the project’s participant pool. Since most
patients discharge on the same day of surgery, the program’s effectiveness was closely measured
within the PACU clinical setting. A chart audit included 64 patients, which calculated the total
opioid consumption in both PACU Phase I and Phase II. This data and preoperative prescribing
practices were taken to the hospital’s Chief Executive Officer (CEO), Chief Nursing Officer
(CNO), Chief of Strategy, and Perioperative Executive Leadership. Organizational support was
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achieved based on opioid administration in the PACU and the strategic goal of implementing
new technologies within the hospital. The DNP project was approved and allowed to move
forward. A SWOT Analysis highlighted the internal and external forces that may impact
implementation (see Figure 3). Plans for sustainability included testing the program in a
microclimate to gain buy-in from stakeholders involved with the project. Executive leadership
supported the idea of scaling virtual reality into all areas of patient care, as well as strategizing to
accomplish a new hospital designation called “Opioid Safe Hospital Designation,” if the program
demonstrates emerging success.
Project Overview
The project's mission was to replace the opioid-centric nursing and physician culture with
opioid-sparing techniques to improve pain management and reduce adverse side effects. The
project's vision addressed the organization’s intention to become a dominant competitor in the
immersive extended realities (XR) market. A 10% reduction of total opioid consumption before
patient discharge from PACU deemed the project's success. A full risk assessment (see Figure 4)
and management plan addressed issues, such as nausea and vomiting during VR usage, fall risk,
or disruption of clinician workflows. Labeled strategies guided the stakeholders to transfer,
accept, mitigate, or eliminate the risks (Kogon, Blakemore, Wood, 2015). The impact and
probability scores ranked the level of influence each risk may play. A subsequent written plan
included communication with specific stakeholders who could support the process and manage
solutions. This was communicated to all nurses during their training.
Objectives
The organization’s Pavilion PACU was the primary setting for the project where the
majority of patients recover in Phase I and transition to Phase II without leaving the department.
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The nursing unit consisted of 12 patient bays and a nursing ratio of 1:2 patients, depending on
the patient's acuity level and type of surgery. Up to 6 nurses employed the unit at one time,
flexing with the census and level of care that patients required. On any given weekday, 1-6
robotic hysterectomy patients underwent surgery, which allowed for an adequate participant
selection. The short-term objective was for clinicians to adhere to protocol guidelines during the
project pilot. The long-term objective was for clinicians to adopt the practices into their
everyday workflow to optimally care for every surgical procedure in a standardized manner.
Stakeholders’ Roles
The DNP student played a vital role as the project lead. Clinical leadership was critical
to facilitate interdisciplinary collaboration and drive change at the nursing bedside (Bender,
Connelly, & Brown, 2012). The project lead facilitated perioperative nursing, anesthesiologist,
and surgeon education. Each healthcare provider maintained a role that was imperative for
project success. The surgeon oversaw all care provided from beginning to end. Their buy-in
was crucial to help support the program and its mission. The anesthesiologists oversaw all
medications given during the perioperative period. Their role was to write specific doctor’s
orders limiting IV opioids and promoting both non-opioid medications and non-pharmacological
techniques. The preoperative nurses were in charge of recruiting participants and educating them
about the new program. The intraoperative nurses drove communication about the project to the
postoperative period, where the PACU nurse initiated the multimodal analgesic virtual reality
program’s pain management protocols. Interprofessional communication amongst all
stakeholders was the foundation of the project’s effectiveness (Busari, Moll, & Duits, 2017).
Project Plan (Method)
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The Model for Improvement guided the DNP Project and allowed stakeholders to
understand how the project measured success and identified opportunities for improvement. The
model required a PDSA cycle, a tool to test rapid improvements for both small and large-scale
projects (Picarillo, 2018). The team was engaged and learned from the project, which allowed
for acceptance or rejection of refined workflows. The knowledge attained affected the system
globally as adoption spread to other areas of the hospital. The project lead was the DNP student.
The nursing preceptor, nursing researcher, and physician champions were the project mentors.
The Planning Stage occurred from October-May 2020. The Do Stage took place during the first
week of June 2020. The Study Stage commenced from the second week of June and ran until the
end of July 2020. Lastly, the Act Stage, or project wrap-up, occurred during August-December
2020. The PDSA cycle and full details regarding the Multimodal Analgesic Virtual Reality
program are outlined below. See Appendix C for the full project schedule.
Planning Stage
The Planning Stage took place from October 2019 to June 2020. This program's structure
was developed based on the literature review and enhanced with both physician and nurse
feedback. Interdisciplinary collaboration guided decision-making for specific practice changes.
The latest evidence-based recommendations for perioperative pain management were embedded
within the program. The DNP student partnered with an anesthesiologist, surgeon, and nursing
Unit Practice Council to help form clinician education and medication administrative practices.
The Director of Extended Reality Therapeutics, the project’s sponsor, decided back in
November 2019 to partner with AppliedVR. This company supports the delivery of safe and
effective VR therapeutic technologies by treating health conditions with evidence-based, noninvasive, and opioid-sparing interventions (AppliedVR, 2019). Since the company was awarded
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a grant by the National Institute on Drug Abuse (NIDA) for more than $2.9 million to study VR
for both acute and chronic pain, it was an easy decision to utilize their technology for the
organization’s patient care needs. The equipment supplied by the company includes the PICO
G2 4K HMD with SootheVR programming, as well as technical support available during regular
business hours, Monday through Friday.
The business proposal for formal implementation and budgetary requirements was
presented to the CEO, CNO, and Chief Strategy Officer back in February 2019. The budget is
outlined in Figure 5. After attaining approval, a plan to reach the stakeholders involved with the
project was created. The DNP nurse created a presentation curated for each healthcare provider
group, including the nurses, anesthesiologists, and gynecology-oncology surgeons. Approval
from each group was granted in May 2020.
Preoperative Setting
During the preoperative period, nurses were responsible for recruiting participants based
on the inclusion and exclusion criteria (see Figure 6), and participants were chosen based on
convenience and opportunity recruitment. Only Hospital Ambulatory Surgical (HAS) patients
were included in the program due to their same-day discharge disposition. Surgical admit
patients were excluded. The nurse introduced the VR head-mounted displays (HMDs) and
instruction pamphlet (see Figure 7) to the patients if the criteria were met. Preoperative
education was conducted on how to use the HMDs in the postoperative period after surgery.
Pain management expectations were addressed by establishing goals for future pain medication
administration. The patients trialed the HMD for about 5 minutes, allowing them to navigate the
simulations and pick between guided-meditation, guided imagery, or interactive games. An
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established time limit ensured operating room (OR) delays did not occur. If time allowed,
patients were allowed to utilize the HMDs for more extended periods.
Anesthesiologists and surgeons were held accountable for ordering at least two
preoperative multimodal analgesic medications, including the combination of acetaminophen,
NSAIDs, COX-2 inhibitors, and gabapentin/pregabalin. The ordering practices depended on
physician preference. Preoperative nurses were in charge of executing the orders and
administering the medications to the patients prior to surgery.
Postoperative Setting
The World Health Organization’s (WHO) Pain Relief Ladder served as the framework
for pain medication administration in the PACU (see Figure 8). As an ethical consideration,
opioids were not withheld from the patients—nurses administered medications based on the pain
relief ladder. For patients who complained of pain on admission on a Numeric Rating Scale
(NRS) 7-10/10, an opioid rescue plan was implemented, and IV opioids were administered to
treat severe pain. For patients who complained of pain on a scale from 1-6/10, VR was utilized
as a non-pharmacological intervention. Oral opioids (i.e., Norco, Percocet, or Roxicodone), in
combination with tramadol and other non-opioid analgesics such as Toradol or Robaxin, were
considered for patients who complained of pain on a scale from 5-6/10. Oral acetaminophen was
administered for patients who complain of pain from 1-4/10.
Since the patients were not appropriate for oral medications immediately after surgery
due to the risk of nausea and vomiting, they received both IV medications and VR as a nonpharmacological intervention until they were optimized for oral medications. Administration of
IV opioids followed EPIC order set instructions to administer the lowest dose initially. The
order also limited administration if the patient met opioid-naïve criteria. If the patient was
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opioid-tolerant (used opioids for one week or longer or around-the-clock use is present of at least
the following daily dose: 60 mg oral morphine, 60 mg oral hydrocodone, 30 mg oral oxycodone,
8 mg oral hydromorphone, fentanyl patch 25 mcg/hr, or the equivalent of another opioid),
dosages increased to meet the needs of the patient following the initial lowest dose.
A VR utilization log sheet accompanied the patient’s chart from the preoperative to
postoperative setting (see Figure 9). The sheet was blue and visually alerted the nurses that the
patient was a project participant. The preoperative nurse was responsible for writing in the
patient’s unique medical record number (MRN) and answering two questions: (1) Did the patient
receive VR training?, and (2) Did the patient receive oral multimodal (≥2) medications in Preop? If the answer to both questions was yes, the preoperative nurse checked the box. Before the
patient transferred to surgery, hand-off communication occurred between the preoperative and
operating room nurses. After the procedure was complete, the operating room nurse
communicated with the PACU nurse and indicated that the patient was a participant in the
multimodal analgesic virtual reality program. PACU nurses admitted the patient to the nursing
unit and ensured the patient was stable and cognitively appropriate for VR. They used the VR
utilization log sheet to document the times the patient was wearing the HMD. A timer was set to
ensure patients did not exceed 30 minutes. The patient could use the headset an unlimited
amount of times, as long as the session did not exceed 30 minutes total. Nurses were allowed to
make comments on the log. For example, if the intervention was discontinued due to nausea, the
nurses wrote this information in the comment section. Once the patient was discharged or
transferred, the log sheet was stored in a locked document box located on the nursing unit. The
project lead was the only team member with access to the locked box. The information was
transferred to a password-protected spreadsheet located on an encrypted, password-protected
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USB flash drive. After moving the data, the sheet was dropped into the organization’s document
shred box.
Do Stage
The Do Stage took place during the first week of June 2020. All perioperative nurses
received a nursing in-service provided in small groups. Attendance was required and supported
by nursing executive leadership. During this time, nurses had the opportunity to test-run the
HMDs on the unit. They had access to the equipment, and monitoring of proper cleaning and
sanitizing procedures occurred. Nurses were required to clean the HMD before and after each
patient’s use with a PDI Sani-Cloth AF# Germicidal Disposable Wipe. A dry optical lens
microfiber cloth or soft gauze was used to clean the headset lens after being wiped with the SaniCloth. If the participant complained of any discomfort (i.e., eye strain, nausea, dizziness, or
headache) during the intervention, including pain caused by the HMD itself, nurses were advised
to discontinue the HMD immediately. Appropriate care was provided based on the risk
management plan presented during the nursing in-services.
Study Stage
The Study Stage commenced during the second week of June and ran until the end of
July 2020. This stage marked the full project implementation phase. To ensure stakeholder bias
was not a factor and workflows were not impacted after the project announcement, the cohort of
64 patients gathered during the needs assessment and practice gap analysis from January to
March 2020 was utilized as the project’s historical pre-intervention group. The program’s
structure was applied to clinician workflows, and data collection on the post-intervention group
was conducted throughout the Study Stage. Data analysis variables were extracted from the
EPIC electronic health record (EHR) and stored in a password-protected spreadsheet located
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within an encrypted USB flash drive. A validated opioid calculator, known as the GlobalRxPh
Opioid Conversions Calculator, was used to convert all IV and oral opioids to an equianalgesic
form of oral morphine milligram equivalents (MME).
Act Stage
The Act Stage took place from August to December 2020. A comprehensive evaluation
of the program and extensive data analysis comparing the pre-intervention group to the postintervention was conducted. The synthesis of evidence was critically appraised, and written
recommendations were presented to the organization’s Executive Leadership team.
Project Evaluation
Evaluation Plan
The project evaluation plan included comparing pre- and post-implementation data and
analyzing if there was a statistically significant clinical difference. An ad hoc selection method
was used to recruit participants dependent on participant accessibility or proximity to the project
(Jager, Putnick, Bornstein, 2017). The collection of pre-implementation data on 64 participants
occurred during June 2020 on patient charts with a date of surgery between January and March
2020. Post-implementation data was collected from the second week of June to the end of July
2020. The reliability and validity of the data collection process remained consistent since there
was only one data collector who ensured the steps were streamlined and uniform. Postimplementation recruitment strategies included selecting participants according to inclusion and
exclusion criteria (see Figure 6). The nurses followed a process map algorithm to determine if
the patient met the criteria. The map walked the nurse through the requirements in a step-wise
fashion. Participants were selected if they were female, undergoing robotic hysterectomy
outpatient surgery, English-speaking, and followed commands appropriately (no cognitive
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deficits). The participants were excluded if they were in isolation precautions, cognitively
impaired, non-English speaking, had open wounds to the head or neck, or had a history of
seizures or claustrophobia.
Ethics, Human Subjects Protection, & Data Protection
Ethics and human subjects’ protection were the project lead’s priority during the project.
Careful consideration of all human subjects’ rights was completed during the proposal
development. The DNP student sought approval from both the EBP Committee (EPRC) from
the University of St. Augustine for Health Sciences and the Institutional Review Board (IRB)
from St. Joseph Hospital as required by the hospital’s policies and procedures. All protected
health information (PHI) was stored on an encrypted flash drive and stored in a locked container
when not in use. The project lead accessed the PHI via a password-protected hospital cloud.
Another password was required to access the EPIC EHR. The anonymity of data was maintained
by transferring the data to a password-protected Excel spreadsheet, only accessible by the project
lead. This document was stored on the encrypted flash drive. Patient names were not transferred
nor published in an identifiable manner. The hospital’s Health Insurance Portability and
Accountability Act (HIPAA) Compliance Officer reviewed all data collection tools before
implementing and after implementing the project, which included the data collection sets. The
project lead received approval at each stage.
Variables
The project lead collected data on multiple variables from both pre- and postimplementation participant groups. The primary variable warranting program success and
feasibility included total opioid consumption converted to MME administered in the PACU
during Phase I and II until patient discharge. The secondary variables included patient medical
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record number (MRN), age, gender, race/ethnicity, body mass index (BMI), American Society of
Anesthesiologists Classification (ASA), diagnosis, preoperative pain score, pain score at
discharge, multimodal analgesia administered in Pre-op, length of stay (LOS) in PACU, and VR
utilization time. The overall evaluation plan outlined variable names, descriptions, data sources,
the possible range of values, levels of measurement (nominal, ordinal, interval, or continuous),
categories of measures, and timeframe for collection (see Appendix D).
Power Analysis and Sample Size Determination
A priori power analysis was conducted to determine the minimum number of participants
required for the project for an 0.80 power of finding a statistically significant difference in the
total opioid administration converted as MME between the multimodal analgesic VR program
and current practice, using the two-sample t-test. The 0.80 power for power analysis is the
desired power of the test. The power analysis for the two-sample t-test was performed using
Gpower 3.1.9.4 (Faul, Erdfelder, Buchner, & Lang, 2009) to determine the minimum sample size
needed for this project. For a medium effect size of 0.5 (Cohen, 1988) and an alpha level = 0.05,
the minimum sample size needed to achieve a .80 power was 128 participants (see Appendix E).
Data Analysis
Data were imported and analyzed using SPSS version 23 for Windows (IBM Corp.,
Armonk, NY). Data were examined using frequency tables and descriptive statistics for
missingness and data entry errors. Participants with missing or erroneous data were excluded
from data analysis, such as those who did not receive both multimodal analgesia in the
preoperative area or those that refused VR in the PACU. Frequency tables (for categorical
variables) and descriptive statistics (for continuous variables) were used to summarize (1)
participants’ demographics, including age, gender, race, BMI, ASA, and diagnosis warranting
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procedure, (2) the event variables, included opioids prior to admission, preoperative pain
score/level, multimodal analgesia administered in pre-op, pain at discharge, IV opioids
administered in PACU, oral opioids administered in PACU, length of stay in PACU, and total
VR utilization time (in minutes), and (3) the primary outcome variable, total opioid consumption
converted as MME, for the two groups (pre-implementation (i.e., current practice) and the postimplementation group (multimodal analgesia + VR). Normality of the continuous study
variables (total VR utilization time, length of stay in PACU, and total opioid consumption
converted as MME) for the two groups (pre-implementation [i.e., current practice] and postimplementation group [multimodal analgesia + VR]) were examined using the Shapiro-Wilk
normality tests (Field, 2013).
The project's primary purpose was to determine if the addition of two non-opioid
interventions would impact the participant’s postoperative opioid consumption. This was done
by measuring if there was a statistically significantly difference in the event variables and the
primary outcome variable between the pre-implementation (i.e., current practice) group and the
post-implementation group that received both EBPs (multimodal analgesia + VR).
Results
The participant size for each of the study groups was: 64 (pre-implementation) and 22
(post-implementation; multimodal analgesia + VR). The categorical population variables of
interest, including gender, race, ASA, and diagnosis for these two study groups are summarized
in Table 1.
All participants were female who underwent the robotic hysterectomy procedure. The
majority of the participants were White in the pre-implementation group (85.9%) and the
multimodal analgesia + VR group (77.3; Table 1). The majority of the participants in the pre-
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implementation group (73.4%) and the multimodal analgesia + VR group (68.2%) had an ASA
classification equal to 2 (Table 2). For diagnosis, about one-third of the participants in the preimplementation group (31.3%) and multimodal analgesia + VR group (31.8%) had a cancerrelated diagnosis (Table 1).
Table 1
Summary (Frequency (%)) of Participants Variables (Gender, Race, ASA, and Diagnosis)
Variable
Pre (N = 64) MA + VR (N = 22)
Gender
Female

64 (100)

22 (100)

Male

0

0

White

55 (85.9)

17 (77.3)

Hispanic

1 (1.6)

0

Asian

5 (7.8)

2 (9.1)

Other

3 (4.7)

3 (13.6)

0

2 (3.1)

0

1

2 (3.1)

2 (9.1)

2

47 (73.4)

15 (68.2)

3

13 (20.3)

5 (22.7)

Cancer

20 (31.3)

7 (31.8)

Other

44 (68.8)

15 (68.2)

Race

ASA

Diagnosis

The continuous participants’ variables of interest, including age and BMI for these two
study groups are summarized in Table 2. The average age for the pre-implementation group and
the multimodal analgesia + VR group was 58.34 (SD = 12.90) and 57.32 (SD = 10.82),
respectively (Table 2). The average BMI for the pre-implementation group and the multimodal
analgesia + VR group was 27.33 (SD = 6.92), 28.86 (SD = 7.32), respectively (Table 2).
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Table 2
Descriptive Statistics (Mean and standard deviation) for Participant Variables (Age and BMI)
Variable Pre (N = 64)
MA + VR (N = 22)
Age

58.34 (12.90)

57.32 (10.82)

BMI

27.33 (6.52)

28.86 (7.32)

Table 3 shows the frequency tables for summarizing the categorical event variables,
including opioids prior to admission, preoperative pain score/level, multimodal analgesia
administered in pre-op, pain at discharge, IV opioids administered in PACU, and oral opioids
administered in PACU, for these two study groups.
Almost all participants in the pre-implementation group (92.2%) and the multimodal
analgesia + VR group (95.5%) had a low level (NRS of 5 or less) of preoperative pain prior to
undergoing surgery (Table 3). Similarly, almost all participants in the pre-implementation group
(98.4%) and all participants (100%) in the post-implementation group (multimodal analgesia +
VR) had low level of pain at discharge (NRS of 5 or less; Table 3).
Table 3
Summary (Frequency (%)) of Categorical Event Variables
Variable
Pre
(N = 64)

MA + VR
(N = 22)

Preoperative pain
Low pain (NRS 0-5)

59 (92.2) 21 (95.5)

High pain (NRS 6-10)

5 (7.8)

1 (4.5)

Multimodal analgesia administered in Pre-op
No

43 (67.2) 0

Yes

21 (32.8) 22 (100)

Pain at discharge
Low pain (NRS 0-5)

63 (98.4) 22 (100)
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1 (1.6)
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0

Table 4 shows the results of the Fisher’s exact tests for determining if there was a
statistical significantly difference in each categorical event variable, including pre-operative pain
score/level, multimodal analgesia administered in pre-op, pain at discharge, between the two
groups of interest; between pre-implementation and multimodal analgesia + VR. According to
Fisher’s exact tests, there was no statistically significant difference in preoperative pain (p =
1.000) and pain at discharge (p = 1.000), between the pre-implementation group and the
multimodal analgesia + VR group (Table 4). However, there was a statistically significant
difference in multimodal analgesia administered in pre-op between the pre-implementation group
and the multimodal analgesia + VR group (p < 0.001) (Table 4).
Table 4
Results of Fisher’s Exact Tests
Variable

Pre vs. MA + VR

Pre-operative pain

1.000

Multimodal analgesia administered in pre-op

< 0.001

Pain at discharge

1.000

Table 5 presents the descriptive statistics of the two continuous event variables (length of
stay and total VR utilization time). According to the results of Shapiro-Wilk normality tests, the
data for length of stay for the pre-implementation group (p = 0.068) and the multimodal
analgesia + VR group (p = 0.263) were normally distributed (Table 5). Thus, mean and standard
deviations were used to summarize length of stay. The average time for length of stay (measured
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in minutes) for the pre-implementation group and the multimodal analgesia + VR group was
156.33 (SD = 65.24) and 162.32 (SD = 44.74), respectively (Table 5).
Table 5
Descriptive Statistics of Continuous Event Variables
Shapiro-Wilk
Variable
Length of stay

VR time

N

M

SD

Mdn

IQR

W

df

p

Pre

64

156.33

65.24

143.0

86.8

0.965

64

0.068

MA + VR

22

162.32

44.74

175.5

56.3

0.946

22

0.263

Pre

64

NA

NA

NA

NA

NA

NA

NA

MA + VR

22

25.64

11.30

29.0

10.0

0.851

22

0.003

Primary Outcome Variable
Table 6 presents the descriptive statistics of the primary outcome variables (total opioid
consumption converted as MME). According to the results of Shapiro-Wilk normality tests, the
data for total opioid consumption converted as MME for the pre-implementation group (p <
0.001) and the multimodal analgesia + VR group (p = 0.002) were not all normally distributed
(Table 6). Thus, median and IQR were used to summarize total opioid consumption converted
as MME. The median total opioid consumption converted as MME for the pre-implementation
group and the multimodal analgesia + VR group was 15.0 (IQR = 30.0) and 12.5 (IQR = 32.5)
respectively (Table 6).
Table 6
Descriptive Statistics of the Primary Outcome Variable
Shapiro-Wilk
Variable

N

M

SD

Mdn

IQR

W

df

p
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30

Pre

64

20.52

22.20

15.0

30.0

0.844

64

< 0.001

MA + VR

22

21.00

24.48

12.5

32.5

0.836

22

0.002

The results of the Mann-Whitney U tests are presented in Table 7. For the comparison
between pre-implementation and multimodal analgesia + VR, the results of the Mann-Whitney U
test indicated that there was no statistically significant difference in total opioid consumption
converted as MME between pre-implementation and multimodal analgesia + VR (U = 686.50, Z
= -0.176, p = 0.860, r = 0.019; Table 7). The median total opioid consumption converted as
MME for the pre-implementation group and the multimodal analgesia + VR group was 15.0
(IQR = 30.0) and 12.5 (IQR = 32.5), respectively (Table 6).
Table 7
Results of Mann-Whitney U tests for Differences in Total Opioid Consumption Converted as
MME (Pre-implementation vs. MA + VR)

Pre vs. MA + VR

N

U

Z

p

r

86

686.50

-0.176

0.860

0.019

Note. U = Mann-Whitney U test statistic; z = standardized test statistic; p = p-value. r = effect
size, computed as |z|/√𝑁, where z is the standardized test statistic and N is the number of total
observations (Tomczak & Tomczak, 2014).
Discussion and Impact
This DNP project compared pre- and post-implementation data for 64 and 22
participants, respectively. A SMART goal outlined the project’s aims—by providing virtual
reality as a non-pharmacological intervention, can nurses decrease opioid exposure by 10%
within the patient’s recovery period? This project was unable to make a statistically significant
impact on total opioid consumption in the PACU clinical setting. However, the analysis of
system-wide effects discovered that nursing knowledge and experience with non-opioid
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medications and VR technology improved—a change in practice that aligns with good clinical
habits that can transfer to different patient environments (Allen et al., 2020).
Initially, the assumption was that an increase in multimodal analgesia and VR techniques
would benefit the patient’s surgical experience by lowering adverse opioid side effects.
Although there wasn’t a statistically significant decrease in opioids, the project guided the
stakeholders to maintain patient-centered approaches. The patient customized their pain
management care, provided feedback to the nurses about their preferred VR simulations, and
decided whether to utilize the headsets after surgery as a pain management tool. As an added
benefit, the nurses used the VR headsets in Pre-op to distract the patients during intravenous (IV)
catheter insertions. In the study done by Glennon et al. (2018), VR technology was used as a
distraction technique and decreased pain and anxiety levels during a bone marrow biopsy and
aspiration procedure. Thus, further research is warranted to explore the effects of VR technology
during percutaneous needle interventions.
The preoperative team demonstrated a significant change in practice during the
implementation of this project. The post-implementation group of participants received
multimodal analgesia 100% of the time, compared to almost a third of the time (32.8%) in the
pre-implementation group. The data also revealed a remarkable difference in a separate group of
participants not initially identified in the evaluation plan. In a group of 27 participants who
received multimodal analgesia medications but refused to utilize the VR technology for
numerous reasons, such as lethargy, nausea, and dizziness, the opioid consumption was
substantially lower (13.59 MME) than the pre-implementation group (20.52 MME). Opioid
consumption also decreased due to ERAS medications in the study done by Cozowics et al.
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(2019). Therefore, this project recommends that multimodal analgesia be standard practice for
all robotic hysterectomy patients undergoing same-day surgery.
Limitations
Various factors may have influenced the results. The evaluation plan included securing
at least 64 participants in the post-implementation group. Unfortunately, this project occurred
during the COVID-19 pandemic. Elective surgeries were canceled temporarily and approved to
return right before the project start date. Therefore, the surgical volume of robotic
hysterectomies was affected, negatively impacting program participants' ad hoc selection. The
post-implementation group only included a total of 22 participants.
As previously mentioned, 27 participants refused VR technology in the PACU due to
complaints of lethargy after general anesthesia, nausea, and dizziness. They also denied the VR
headset if their pain was well managed—an unexpected barrier that hindered participant
inclusion. Nurses did their best to minimize this limitation by promoting VR technology as a
therapeutic intervention through patient education. However, anesthesiologists and nurses
should consider altering their practice to reduce the aforementioned adverse effects. With the
introduction of multimodal analgesia, clinicians may need to balance the administration of
anesthetics and analgesics in addition to frontloaded pain management interventions.
Given the potential for significant improvement in pain management techniques, future
EBP change projects may address using VR technology in other perioperative clinical settings,
such as during the preoperative IV insertions or in lieu of anesthesia administration during
minimally invasive procedures. Nursing practice should also mimic the best practices
recommended. Furthermore, this project could be duplicated with an extended timeframe for
data collection, ideally without outside factors influencing patient surgical volumes.
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Plans for Dissemination
Plans for regional dissemination of this DNP project began in the fall of 2020. On
Friday, October 9th, 2020, the DNP student presented at the organization’s first annual Virtual
Reality Symposium hosted by the hospital’s Director of Extended Reality and Digital
Therapeutics. The symposium’s objectives focused on translational and implementation science
and methods to incorporate innovative technologies at the clinical bedside. Virtual reality
industry leaders, various community hospital executives interested in leading technology and
potential organization donors were present at this meeting. The DNP student’s goals included
presenting the results and outcomes of the DNP project and acting as a nursing leader in the
transforming field of virtual reality.
Organizational dissemination of the final DNP project started in November 2020. The
DNP student created educational content for the Acute Care Nursing Conference. Presentations
and educational material were organized according to the audience members in attendance and
included information on practice transformation within the perioperative setting.
The national plan for dissemination included submitting an abstract for podium session at
the Western Institute of Nursing (WIN) Conference and for a poster presentation at the
Association of peri-Operative Registered Nurses (AORN) Global Surgical Conference &
Exposition. Abstract submissions occurred during October 2020. The WIN Conference is held
in Salt Lake City from April 14-17, 2021. The abstract considerations are expected by the
beginning of the 2021. The AORN Global Surgical Conference & Exposition is scheduled for
August 7-11, 2021 in Orlando, Florida. Abstract determinations may be considered during the
spring season.
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Although several plans were in place for dissemination, the DNP student built the
capacity for change and adaptation as the novel coronavirus impacted society. Dependent on the
recommendations from the CDC, conferences with large gatherings were prohibited. Therefore,
strategies for dissemination shifted to webinar-based platforms, digital posters, and online
journal publications. As a university requirement, a full-text scholarly publication is available in
the University of St. Augustine for Health Sciences institutional repository called SOAR@USA.
Conclusion
The Multimodal Analgesic Virtual Reality Program’s intended purpose was to provide a
formative answer to society’s opioid epidemic by reducing immediate postoperative opioid
exposure and usage. Healthcare providers had the chance to positively influence the crisis by
providing patients with evidence-based treatments and best practices for substance abuse
prevention (Naegle, Mitchell, Flinter, Dunphy, Vanhook, & Delaney, 2017). Nurses,
anesthesiologists, and surgeons worked together on this project to support the combination of
non-opioid, multimodal analgesia and VR as a non-pharmacological intervention. This project
focused on an opioid-sparing culture and required a coordinated, interdisciplinary team effort to
change actions and policies.
Using the Model for Improvement, the DNP student acted as the nursing project lead and
drove juxtaposed evidence-based practice changes along a timeline. The PDSA cycle ran from
October 2019 to December 2020 and provided the rapid cycle culture change agenda.
Numerable variables measured pre- and post-implementation of the program to capture if the
healthcare providers’ variation in practice contributed to the project’s success.
There was no statistically significant difference in total opioid consumption converted as
morphine milligram equivalents (MME) between the pre-implementation and post-
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implementation groups. However, there was a statistically significant difference in multimodal
analgesia administered in Pre-op between the pre-implementation and post-implementation
groups. Therefore, the execution of the multimodal analgesic VR program allowed for nursing
adoption of novel evidence-based practices (EBP) and promoted the use of non-opioid and nonpharmacological interventions. Although the combination of multimodal analgesia and VR did
not reduce opioid consumption, the practice of incorporating multimodal analgesia as a standard
workflow improved.
In conclusion, this project helped mitigate the potential for opioid abuse by providing
clinicians other proven methods to treat pain effectively. A formal plan for disseminating its
results was in place to attract buy-in from stakeholders within the organization and improve
scalability to other nursing departments. The long-term objective remains active at the nursing
bedside. Clinicians continue to adopt EBPs into their everyday workflow and pave the way for
safe, quality care for patients exposed to opioids in the perioperative setting.
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VR – Virtual reality

test, Z test
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applications.
Patients using
HMDs saw a
greater decrease
in pain
postoperatively.

contrary to lipoma
removals.
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Appendix B
Table 2. Summary of Systematic Reviews (SR)
Citation

Brubaker,
L., Kendall,
L., & Reina,
E. (2016).
Multimodal
analgesia: A
systematic
review of
local
NSAIDs for
nonophthalmolo
gic
postoperativ
e pain
management
. Internation
al Journal of
Surgery, 32,
158–166.
doi:
10.1016/j.ijs
u.2016.07.0
03

Level of Question
Search Strategy
Evidence
/
Quality
Grade
I/Good To analyze the
Electronic
role of NSAIDS databases: PubMed
in nonMEDLINE,
ophthalmologic Cochrane Central
postoperative pain Register of
management.
Controlled Trials
(CENTRAL)

Mallari, B., I/Good
Spaeth, E.
K., Goh, H.,
& Boyd, B.
S. (2019).

To compare the
effectiveness on
VR in adults with
both acute and
chronic pain

Electronic
databases:
TRIP, CINAHL,
MEDLINE (via
PubMed)

Inclusion/
Exclusion Criteria

Data Extraction
and Analysis

Key Findings

Usefulness/
Recommendation/
Implications

Inclusion criteria:
Randomized controlled
studies comparing
NSAIDs and standard
procedures/placebo

Independent
screening yielded
142 studies. 9
RCTs were
included. Risk of
bias was assessed
using the Cochrane
Risk of Bias
instrument.
Overall quality was
measured using the
GRADE approach.

Low to moderate
quality evidence
supporting the use of
NSAIDs both
preoperatively and
postoperatively in
addition to standard
post-surgical pain
management. Low to
moderate quality
evidence that NSAID
administration
improves function.

Standardized
administration methods
for NSAIDs lacks
within research.
Unable to make a
summary statement due
to a small number of
RCTs. Further research
is required for
recommendations
regarding safer, costeffective interventions.

Exclusion criteria: No
comparison or
comparison group
received intramuscular
NSAIDs, as opposed to
IV or oral.

Inclusion criteria:
Two researchers
“immersive” VR, English identified 485
articles, dated January
articles. Total of
2007 to December 2018, 20 articles were
adults ≥ 18 years old,
included; 14 RCTs,

VR is an effective tool Pain intensities can be
to reduce acute pain reduced with VR when
during various
patients have acute
medical procedures. pain.
There are inconsistent Recommendations
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Citation

Level of Question
Evidence
/
Quality
Grade

Virtual
reality as an
analgesic for
acute and
chronic pain
in adults: a
systematic
review and
metaanalysis. Jou
rnal of Pain
Research, V
olume 12,
2053–2085.
doi:
10.2147/jpr.
s200498
Scapin, S., II/Good
EchevarríaGuanilo, M.
E., Junior, P.
R. B. F.,
Gonçalves,
N., Rocha,
P. K., &
Coimbra, R.
(2018).
Virtual
reality in the
treatment of
burn
patients: A
systematic
review. Bur
ns, 44(6),

Search Strategy

Inclusion/
Exclusion Criteria

pain intensity as the
outcome measure
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Data Extraction
and Analysis

Key Findings

6
findings for pain
quasiexperimental reduction in patients
studies. The PEDro with chronic pain.
Exclusion criteria:
tool was used to
“nonimmersive” VR,
analyze risk of bias
nonexperimental studies, for RCTs. The
experimental pain,
Modified Downs
studies published before and Black
2007
(MD&B) quality
index was applied
to nonrandomized
studies.

To identify the
main effects of
virtual reality for
burn patients.

Electronic
databases:
LILACS, BDENF,
SciELO, CINAHL,
Web of Science,
PubMed/MEDLIN
E, SCOPUS,
Academic Search
Complete,
PsycINFO

Inclusion criteria:
Complete works
included, such as original
articles and case reports
Exclusion criteria:
Revisions, letters,
reviews, editorials, and
duplicate studies

Usefulness/
Recommendation/
Implications

include evaluating the
cost-effectiveness of
VR as an adjunctive
pain tool.

34 studies
VR is an effective tool VR is a proven,
analyzed; 23 RCTs, for managing both
effective non3 controlled and
psychosocial and
pharmacological
non-randomized
neurosensitive factors intervention for pain in
clinical trials—
related to pain. VR burn patients. It also
level of evidence has demonstrated, on benefits other
based on the
magnetic resonance consequences of pain,
Cochrane
imaging, reduced
such as anxiety.
classification.
activation of CNS
pain regions in the
brain. VR also works
as a distraction
mechanism, deviating
the user’s focus away
from pain, thus
reducing the need for
medication.
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Citation

Level of Question
Evidence
/
Quality
Grade
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Search Strategy

Inclusion/
Exclusion Criteria

Data Extraction
and Analysis

Electronic
databases:
Cochrane Library,
Ovid MELINE,
Embase, CINAHL,
ERIC, NIHR
Centre for Review
and Dissemination,
Proquest

Inclusion criteria:
48 full text articles
Peer-reviewed journal, found; 11 RCTs, 9
examined effect of VR on crossover studies,
acute pain, measured pain 20 qualitative
scores
syntheses.
Cochrane risk of
Exclusion criteria:
bias assessment
Lacked intervention for tool was used for
pain, non-VR control
parallel group
group, and experimental RCTs. The tool
design
was modified for
crossover trials.

Key Findings

Usefulness/
Recommendation/
Implications

1403–1416.
doi:
10.1016/j.bu
rns.2017.11.
002
Chan, E.,
II/High
Foster, S.,
Sambell, R.,
& Leong, P.
(2018).
Clinical
efficacy of
virtual
reality for
acute
procedural
pain
management
:A
systematic
review and
metaanalysis. Plo
s
One, 13(7).
doi:
10.1371/jour
nal.pone.020
0987

Legend:

Comprehensively
assess the
efficacy of virtual
reality as a pain
intervention.

The meta-analysis
Early evidence suggests
conducted showed
that VR is effective for
that VR had a positive treating pain during
influence on pain
burn physical therapy
scores. However, its and needle studies.
effects vary between There is a need for
different procedures, higher-quality studies to
where needle studies validate the widespread
and burn physical
adoption of VR.
therapy showed the
most benefit. Since
VR is a non-blindable
intervention, bias was
present throughout the
review.
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BDENF – Base de Dados de Enfermagem
CINAHL – Cumulative Index to Nursing & Allied Health Literature
CNS – Central nervous system
GRADE – Grading of Recommendations Assessment, Development and Evaluation
LILACS – Latin American and Caribbean Health Sciences Literature
RCT – Randomized control trial
TRIP – Turning Research into Practice
SciELO – Scientific Electronic Library Online
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Appendix C
Project Schedule
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Week 3

X

NUR7803

Week 1

X

Week 15

X

Week 13

X

Week 11

X

Week 9

Week 7

Week 3

NUR7802

Week 5

Meet with preceptor
and project champions
Needs
assessment/practice
gap analysis
Create a project
budget
Seek Executive
Leadership Approval
Conduct literature
review
Prepare project
proposal
Obtain project
stakeholder approval
Obtain university EBP
committee approval
Obtain hospital IRB
approval
Offer nursing
education in-services
Begin HMD test-run
and document
observations/
unexpected findings
Begin project pilot
implementation
Begin data collection
Comprehensive
statistical analyses
Analyze efficacy of
program

Week 1

Activity

NUR7801
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X
X

X

X
X

X

X
X
X
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Week 11

Week 13

Week 15

Week 7

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7803

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

NUR7802

Week 9

Evaluate feasibility
and sustainability of
program
Disseminate learning
to organization
Begin planning for
next PDSA cycle

Week 1

Activity

NUR7801
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Appendix D
Table 3. Evaluation Plan
Variable Name
Population

Data
Source
EPIC

Possible Range of
Values
N/A

Level of
Measurement
Nominal

Categories of
Measures
N/A

Timeframe for
Collection
Pre- and Postintervention

EPIC

18-100

Continuous

N/A

Gender

Variable
Description
Unique assigned
medical record
number
Age at start of
intervention
Gender

EPIC

0 = male, 1 = female

Dichotomous

N/A

Race/Ethnicity

Race/Ethnicity

EPIC

Nominal

N/A

BMI

Body Mass Index

EPIC

0 = White, 1 =
Hispanic, 2 = Black,
3 = Asian, 4 = Other
15-50

Pre- and Postintervention
Pre- and Postintervention
Pre- and Postintervention

Continuous

N/A

ASA

American Society of
Anesthesiologists
Classification

EPIC

I-IV

Ordinal

N/A

Diagnosis

Diagnosis
warranting
procedure
Pain number using
validated screening
tool reported prior
to surgery
Pain number using
validated screening
tool
≥ 2 oral, non-opioid
pain medications
given in Pre-op

EPIC

0 = Other, 1 =
Cancer

Dichotomous

N/A

Pre- and Postintervention

EPIC

0 = Low Pain (0-5),
1 = High Pain (6-10)

Nominal

Outcome

Pre- and Postintervention

EPIC

0 = Low Pain (0-5),
1 = High Pain (6-10)

Dichotomous

Pre- and Postintervention

EPIC

0 = No, 1 = Yes

Dichotomous

Length of stay; Both
Phase I and Phase II
Combined in

EPIC

15-360

Continuous

Process,
Balancing,
Sustainability
Outcome, Process,
Balancing,
Financial,
Sustainability
Process,
Balancing,
Financial

Patient MRN

Age

Event

Preoperative
Pain Score

Pain at
Discharge
Multimodal
Analgesia
Administered
in Pre-op
LOS - PACU

Pre- and Postintervention
Pre- and Postintervention

Pre- and Postintervention

Pre- and Postintervention
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Minutes

VR Time
Primary
Outcome
Variable

Total Opioid
Consumption

Total VR utilization
time in minutes
Opioids converted
to oral morphine
milligram
equivalents (MME)
administered in
PACU Phase I & II
until discharge

Log Sheet

0-120

Continuous

EPIC

0-100

Nominal

Process,
Sustainability
Outcome, Process,
Balancing,
Financial,
Sustainability

Pre- and Postintervention
Pre- and Postintervention
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Gpower Sample Size Calculation
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